Glucose Proamp Laboratoire Aguettant (Glucose)

Glucose Proamp is indicated for situations where rapid provision of carbohydrate energy is required. It is commonly employed in clinical settings for the following purposes:

• Treatment of documented hypoglycemia in adults and children.
• Component of parenteral nutrition regimens to supply calories.
• Fluid replacement when combined with electrolytes.
• Intra‑operative or peri‑operative glucose support.
• Management of electrolyte disturbances associated with low blood glucose.

Side effects of intravenous glucose solutions are generally related to the metabolic and local effects of the infusion.

Common

• Transient hyperglycemia or elevated blood glucose levels.
• Local irritation or phlebitis at the infusion site.
• Mild electrolyte shifts, particularly sodium and potassium.
• Fluid overload when administered rapidly.
• Nausea or abdominal discomfort.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Anaphylactic or severe allergic reaction.
• Cardiac arrhythmias associated with rapid glucose shifts.
• Hyperosmolar hyperglycemic state in susceptible patients.
• Acute renal dysfunction secondary to volume overload.

When using Glucose Proamp, clinicians should observe several safety measures to minimize risks. Important precautions include:

• Regular monitoring of blood glucose concentrations during and after infusion.
• Adjusting infusion rates in patients with renal or hepatic impairment.
• Using aseptic technique to prevent catheter‑related infections.
• Exercising caution in pregnant or breastfeeding individuals, as safety data are limited.
• Evaluating pediatric patients carefully, with dose individualized by weight.
• Avoiding rapid bolus administration unless clinically indicated.

Glucose Proamp may interact with other agents that affect blood glucose or electrolyte balance.

Avoid

• Concurrent high‑dose insulin or insulin analogues that could precipitate severe hypoglycemia.
• Sulfonylureas or other oral hypoglycemic agents without appropriate glucose monitoring.

Use with caution

• Diuretics that may alter sodium and potassium levels.
• Beta‑blockers, which can mask hypoglycemia symptoms.
• Corticosteroids or catecholamines that raise blood glucose.
• Potassium‑containing solutions, due to potential shifts in serum potassium.
• Other intravenous carbohydrate solutions, to prevent excessive caloric load.